BioLargo, Inc. Announces 2024 Annual Meeting of Stockholders on June 13, 2024
Ticker: BLGO · Form: DEF 14A · Filed: Apr 26, 2024 · CIK: 880242
Sentiment: neutral
Topics: BioLargo, Annual Meeting, Proxy Statement, Stockholders, Corporate Governance
TL;DR
<b>BioLargo, Inc. will host its 2024 Annual Meeting of Stockholders on June 13, 2024, in Aliso Viejo, California.</b>
AI Summary
BIOLARGO, INC. (BLGO) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. BioLargo, Inc. will hold its 2024 Annual Meeting of Stockholders on June 13, 2024, at 10:00 a.m. Pacific Time. The meeting will take place at the Aliso Viejo Country Club, 33 Santa Barbara Drive, Aliso Viejo, California 92656. Stockholders are encouraged to vote promptly by signing and returning the proxy card or voting via the website. The proxy statement contains information regarding the business to be transacted at the meeting. The company was formerly known as NUWAY MEDICAL INC, NUWAY ENERGY INC, and LATIN AMERICAN CASINOS INC.
Why It Matters
For investors and stakeholders tracking BIOLARGO, INC., this filing contains several important signals. This meeting is a crucial opportunity for shareholders to engage with management, vote on important company matters, and influence the company's direction. The proxy statement provides essential details about the agenda and voting procedures, ensuring shareholders can make informed decisions.
Risk Assessment
Risk Level: low — BIOLARGO, INC. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.
Analyst Insight
Stockholders should review the proxy statement carefully to understand the proposals and vote their shares to ensure their voice is heard.
Key Numbers
- June 13, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
- 10:00 a.m. Pacific Time — Annual Meeting Time (2024 Annual Meeting of Stockholders)
- 000-19709 — SEC File Number (BioLargo, Inc. SEC File Number)
- 20030205 — Name Change Date (Former Company Name NUWAY MEDICAL INC)
Key Players & Entities
- BIOLARGO, INC. (company) — Registrant
- June 13, 2024 (date) — Date of Annual Meeting
- Aliso Viejo Country Club (company) — Location of Annual Meeting
- Dennis P. Calvert (person) — President and Chief Executive Officer
- NUWAY MEDICAL INC (company) — Former Company Name
- NUWAY ENERGY INC (company) — Former Company Name
- LATIN AMERICAN CASINOS INC (company) — Former Company Name
- 14921 CHESTNUT ST. (address) — Company Business Address
FAQ
When did BIOLARGO, INC. file this DEF 14A?
BIOLARGO, INC. filed this Proxy Statement (DEF 14A) with the SEC on April 26, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by BIOLARGO, INC. (BLGO).
Where can I read the original DEF 14A filing from BIOLARGO, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by BIOLARGO, INC..
What are the key takeaways from BIOLARGO, INC.'s DEF 14A?
BIOLARGO, INC. filed this DEF 14A on April 26, 2024. Key takeaways: BioLargo, Inc. will hold its 2024 Annual Meeting of Stockholders on June 13, 2024, at 10:00 a.m. Pacific Time.. The meeting will take place at the Aliso Viejo Country Club, 33 Santa Barbara Drive, Aliso Viejo, California 92656.. Stockholders are encouraged to vote promptly by signing and returning the proxy card or voting via the website..
Is BIOLARGO, INC. a risky investment based on this filing?
Based on this DEF 14A, BIOLARGO, INC. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.
What should investors do after reading BIOLARGO, INC.'s DEF 14A?
Stockholders should review the proxy statement carefully to understand the proposals and vote their shares to ensure their voice is heard. The overall sentiment from this filing is neutral.
Risk Factors
- Filing of Proxy Statement [low — regulatory]: The company is filing a Definitive Proxy Statement (DEF 14A) to provide information to stockholders regarding the 2024 Annual Meeting.
Key Dates
- 2024-06-13: 2024 Annual Meeting of Stockholders — Key date for shareholder participation and voting.
- 2024-04-26: Filing Date of DEF 14A — Indicates when the proxy materials were officially submitted to the SEC.
Glossary
- DEF 14A
- Definitive Proxy Statement (This is the official document filed by BioLargo, Inc. to solicit proxies from shareholders for the annual meeting.)
- Proxy Card
- A card or form that allows a shareholder to vote on matters before the meeting without attending in person. (Essential for shareholders to cast their votes on company proposals.)
Filing Stats: 4,718 words · 19 min read · ~16 pages · Grade level 10.8 · Accepted 2024-04-26 15:32:27
Key Financial Figures
- $100 million — oulder Colorado, where she controlled a $100 million commercial loan portfolio and underwrot
- $120 million — n portfolio and underwrote in excess of $120 million in loans. From October 2015 to November
Filing Documents
- blgo20240426c_def14a.htm (DEF 14A) — 526KB
- bl01.jpg (GRAPHIC) — 238KB
- bl02.jpg (GRAPHIC) — 99KB
- bl03.jpg (GRAPHIC) — 209KB
- blgo01.jpg (GRAPHIC) — 6KB
- chart01.jpg (GRAPHIC) — 35KB
- chart02.jpg (GRAPHIC) — 36KB
- chart03.jpg (GRAPHIC) — 37KB
- sig01.jpg (GRAPHIC) — 3KB
- 0001437749-24-013406.txt ( ) — 1441KB
Executive Compensation
Executive Compensation 12
Security Ownership of Certain Beneficial Owners and Management
Security Ownership of Certain Beneficial Owners and Management 20 Certain Relationships and Related Transactions 20 Report of Compensation Committee 21 Proposal Two: Advisory vote on executive compensation 22 Proposal Three: Ratification of selection of independent registered public accounting firm 23 Principal Accountant Fees and Services 23 Report of Audit Committee 24 Proposal Four: Approval of 2024 Equity Incentive Plan 25 Index of Exhibits Appendix A: Form of Notice of Internet Availability of Proxy Materials Appendix B: 2024 Equity Incentive Plan 4 Table of Contents BIOLARGO, INC. PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS INFORMATION CONCERNING SOLICITATION AND VOTING The enclosed Proxy is solicited on behalf of the Board of Directors of BioLargo, Inc. ("BioLargo" or the "Company"), for use at the Annual Meeting of Stockholders to be held on Thursday, June 13, 2024, at 10:00 a.m. local time (the "Annual Meeting"), and at any postponement or adjournment thereof. The Annual Meeting will be held at Aliso Viejo Country Club, 33 Santa Barbara Drive, Aliso Viejo, California 92656. The purposes of the Annual Meeting are set forth in the accompanying Notice of Annual Meeting of Stockholders. As permitted by the rules adopted by the Securities and Exchange Commission, or SEC, we are making these proxy solicitation materials and the Annual Report for the fiscal year ended December 31, 2023, including the financial statements, available to our stockholders electronically via the Internet. A Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how to access our Proxy Statement and Annual Report for the fiscal year ended December 31, 2023, and how to vote will be mailed on or about May 3, 2024, to all stockholders entitled to vote at the meeting. Our principal executive offices are located at 14921 Chestnut St., Westminster, California 92683. Our telephone number is (8